Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-21 · accession 0001567619-21-013915 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-23 | 2021-07-21 | ANGO | Tarnoff Michael E | Dir | A - Grant | $0.00 | +5,738 | 21.1K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-21 | A | A | 5,738 | $0.00 | 21,061 | D | — | — | (F1) The acquisition of 5,738 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 5,738 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/21/2022. |